Back
Esperion Therapeutics Stock Price Chart
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
26
ESPR
Esperion Therapeutics
Last Price:
1.70
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESPR is experiencing selling pressure, which indicates risk of future bearish movement.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Sell |
| 20-day SMA: | 1.75 | Sell |
| 50-day SMA: | 2.02 | Sell |
| 200-day SMA: | 2.26 | Sell |
| 8-day EMA: | 1.76 | Sell |
| 20-day EMA: | 1.79 | Sell |
| 50-day EMA: | 1.95 | Sell |
| 200-day EMA: | 2.18 | Sell |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 43.29 | Sell |
| Chaikin Money Flow: | -2830662 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 1.86) | Sell |
| Bollinger Bands (100): | (1.85 - 2.51) | Sell |
Esperion Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 1.74 while ESPR 8-day simple moving average is 1.77, which is a Sell signal.
- The stock price of ESPR is 1.74 while Esperion Therapeutics 20-day SMA is 1.75, which makes it a Sell.
- Esperion Therapeutics 50-day simple moving average is 2.02 while ESPR share price is 1.74, making it a Sell technically.
- ESPR stock price is 1.74 and Esperion Therapeutics 200-day simple moving average is 2.26, creating a Sell signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
26
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a Sell
The current Esperion Therapeutics [ESPR] share price is $1.74. The Score for ESPR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
340.45M
Price in USD:
1.74
Share Volume:
3.09M
Esperion Therapeutics 52-Week Range
52-Week High:
3.40
52-Week Low:
0.70
Sell
26
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?
The Esperion Therapeutics stock price is 1.74 USD today. -
Will ESPR stock go up or go down?
Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Esperion Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 1.74 while ESPR 8-day exponential moving average is 1.76, which is a Sell signal.
- The stock price of ESPR is 1.74 while Esperion Therapeutics 20-day EMA is 1.79, which makes it a Sell.
- Esperion Therapeutics 50-day exponential moving average is 1.95 while ESPR share price is 1.74, making it a Sell technically.
- ESPR stock price is 1.74 and Esperion Therapeutics 200-day simple moving average is 2.18, creating a Sell signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.13 per share, an increase this year of $1.82 per share, and an increase next year of $0.19 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
- ESPR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Esperion Therapeutics is a Sell
- Esperion Therapeutics Relative Strength Index (RSI) is 43.29, which suggest Esperion Therapeutics is oversold
- The Bollinger Bands (25) for Esperion Therapeutics is (1.7 - 1.86), which suggest Esperion Therapeutics is a Sell
- The Bollinger Bands (100) for Esperion Therapeutics is (1.85 - 2.51), which suggest Esperion Therapeutics is a Sell
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.